Medidata Opens New, Larger London EMEA Headquarters
September 27 2017 - 8:30AM
Business Wire
Europe/EMEA Experiencing Rapid Growth,
Expanded New Facilities to Meet Demand
Medidata (NASDAQ:MDSO), the leading global provider of
cloud-based technology and data analytics for clinical research,
today announced the official opening of its new EMEA headquarters
at 12 Hammersmith Grove, London, to facilitate the company’s
continued expansion in the region.
Europe is one of Medidata’s fastest growing markets, serving
various customers, including big pharma, biotech and medtech
companies and leading CROs. The Company has a strong and increasing
presence in the region, with offices in London and Dusseldorf and a
data center in Frankfurt, with plans to expand into additional
European Life Sciences hubs.
London has been the location of the Company’s EMEA Headquarters
for over ten years and serves as a pivotal hub for the region’s
sales and marketing operations and a global hub for R&D.
Medidata has built a strong workforce in London of over 240 highly
skilled employees and has established long term, trusted
relationships with customers in the UK, including AstraZeneca,
GlaxoSmithKline, Novartis and Roche.
“I am delighted that Medidata are reaffirming their commitment
to Hammersmith and London as they move into their brand new and
improved EMEA headquarters. The UK life sciences sector is globally
leading, with a scientific, regulatory and industrial centre of
excellence,” said Philip Dunne MP, Minister of State for Health.
“As a government, we are deeply committed to helping the life
sciences sector flourish and it gives me great pleasure to
celebrate this achievement with Medidata, as the company continues
its work improving patient lives.”
“We chose London as our EMEA headquarters over ten years ago due
to the high concentration of innovative, international life
sciences companies, a strong R&D presence and a talented,
diverse workforce. The UK continues to be an attractive market for
Medidata,” said Tarek Sherif, Medidata Chairman and CEO. “This is
an important investment for the Company, demonstrating our
increased commitment to the UK and the strategic importance of the
EMEA region. We are delighted to move to new, expanded headquarters
in London that will provide space to attract new talent over the
next few years. I look forward to leveraging the opportunities
provided by this expansion to meet the strong growth demand in the
region and continue to attract and retain talented and skilled
employees.”
The Company hosted an opening reception at 12 Hammersmith Grove
on the 26th of September. Medidata executive management, including
Tarek Sherif (Chairman and CEO), Glen de Vries (President), Mike
Capone (Chief Operating Officer) and Christian Hebenstreit
(Managing Director, EMEA) were present to celebrate this landmark
with Medidata employees, customers and members of the local
council.
About Medidata
Medidata is reinventing global drug and medical device
development by creating the industry's leading cloud-based
solutions for clinical research. Through our advanced applications
and intelligent data analytics, Medidata helps advance the
scientific goals of life sciences customers worldwide, including
over 850 global pharmaceutical companies, biotech, diagnostic and
device firms, leading academic medical centers, and contract
research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled
clinical trial data assets provide deep insights that pave the way
for future growth. The Medidata Clinical Cloud is the primary
technology solution powering clinical trials for 18 of the world's
top 25 global pharmaceutical companies and is used by 18 of the top
25 medical device developers—from study design and planning through
execution, management and reporting.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170927005399/en/
Medidata Solutions:Investors:Anthony D’Amico,
+1-732-767-4331adamico@mdsol.comorMedia:Erik Snider,
+1-646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024